Back to Journals » ClinicoEconomics and Outcomes Research » Volume 5

Review

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

       
Total article views   HTML views PDF downloads Totals
14,763 Dovepress* 11,882+ 2,626 14,508
PubMed Central* 2,881 1,054 3,935
Totals 14,763 3,680 18,443
*Since 11 April 2013
+Since July 2016

View citations on PubMed and Google Scholar